# Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)

> **NCT01353066** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 240 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease
- Subclinical Disease and/or Syndrome

## Interventions

- **DRUG:** Intensive Medical Treatment
- **OTHER:** IMM+Roux-en-Y Gastric Bypass (RYGBP)

## Key facts

- **NCT ID:** NCT01353066
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2011-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353066, "Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01353066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*